北京市醫(yī)藥制造產(chǎn)業(yè)發(fā)展研究
發(fā)布時(shí)間:2018-04-14 02:06
本文選題:醫(yī)藥制造產(chǎn)業(yè) + 醫(yī)藥產(chǎn)業(yè)發(fā)展; 參考:《首都經(jīng)濟(jì)貿(mào)易大學(xué)》2015年碩士論文
【摘要】:醫(yī)藥制造產(chǎn)業(yè)是我國(guó)國(guó)民經(jīng)濟(jì)的重要組成部分,同時(shí)也是關(guān)系到國(guó)民健康安全和社會(huì)穩(wěn)定的特殊產(chǎn)業(yè)。隨著我國(guó)對(duì)外開放步伐的加快、國(guó)民收入的提高、國(guó)民健康意識(shí)的增強(qiáng),以及政府對(duì)醫(yī)療體制改革的不斷深化,北京市醫(yī)藥制造產(chǎn)業(yè)逐漸顯現(xiàn)出了持續(xù)增長(zhǎng)的勢(shì)頭和巨大的市場(chǎng)潛力。伴隨整個(gè)醫(yī)藥產(chǎn)業(yè)的市場(chǎng)競(jìng)爭(zhēng)愈加激烈,北京市作為首都醫(yī)藥經(jīng)濟(jì)發(fā)展重點(diǎn)城市,其發(fā)展歷程、發(fā)展特征和發(fā)展?jié)摿Χ挤浅>哂写硇?值得深入探討。近年來(lái),高技術(shù)產(chǎn)業(yè)的發(fā)展越來(lái)越快速,競(jìng)爭(zhēng)越來(lái)越激烈。隨著現(xiàn)代醫(yī)學(xué)、化學(xué)、生物等學(xué)科知識(shí)的發(fā)展進(jìn)步,北京市醫(yī)藥制造產(chǎn)業(yè)也被注入了前所未有的發(fā)展活力和動(dòng)力。在整個(gè)社會(huì)經(jīng)濟(jì)中,醫(yī)藥制造產(chǎn)業(yè)作為增長(zhǎng)速度最快的高新技術(shù)產(chǎn)業(yè)之一,也被稱之為“永不衰落的朝陽(yáng)產(chǎn)業(yè)”,在地區(qū)經(jīng)濟(jì)中的地位日益重要。近年來(lái)醫(yī)藥制造產(chǎn)業(yè)發(fā)展迅速,在全球醫(yī)藥市場(chǎng)激烈競(jìng)爭(zhēng)的大環(huán)境下面臨著重大的挑戰(zhàn)和機(jī)遇。與此同時(shí),與發(fā)達(dá)國(guó)家和地區(qū)相比,北京市醫(yī)藥制造產(chǎn)業(yè)的規(guī)模效應(yīng)還比較弱勢(shì),發(fā)展起步較晚,尚存在許多地域性差異和制約因素,造成了整體市場(chǎng)競(jìng)爭(zhēng)力較弱,個(gè)體發(fā)展不均衡等問題。北京市作為我國(guó)首都,是中國(guó)經(jīng)濟(jì)發(fā)展的重要地區(qū),本文主要以北京醫(yī)藥市場(chǎng)為研究對(duì)象,從北京市乃至全國(guó)藥品市場(chǎng)的現(xiàn)狀出發(fā),通過(guò)各種實(shí)例比較和驗(yàn)證,從不同的角度分析北京市醫(yī)藥制造產(chǎn)業(yè)的發(fā)展,用SWOT方法詳細(xì)解讀北京市醫(yī)藥制造產(chǎn)業(yè)面臨的機(jī)遇與挑戰(zhàn),并從醫(yī)藥企業(yè)面臨的內(nèi)外部環(huán)境和所處的變革等方面分析和探討醫(yī)藥制造產(chǎn)業(yè)未來(lái)的發(fā)展趨勢(shì)和方向。
[Abstract]:Pharmaceutical manufacturing industry is an important part of China's national economy, but also a special industry related to national health and security and social stability.With the acceleration of the pace of opening to the outside world, the improvement of national income, the enhancement of national health awareness, and the deepening of the government's reform of the medical system,Beijing pharmaceutical manufacturing industry has gradually shown the momentum of sustained growth and huge market potential.With the increasingly fierce market competition in the whole pharmaceutical industry, Beijing, as a key city in the development of the capital pharmaceutical economy, is very representative in its development process, development characteristics and development potential, which is worthy of further discussion.In recent years, the development of high-tech industry is more and more rapid, the competition is more and more intense.With the development of modern medicine, chemistry, biology and other disciplines, the pharmaceutical manufacturing industry in Beijing has been injected with unprecedented vitality and power.In the whole social economy, the pharmaceutical manufacturing industry, as one of the fastest growing high-tech industries, is also called the "rising sun industry", which plays an increasingly important role in the regional economy.In recent years, pharmaceutical manufacturing industry is developing rapidly, and it faces great challenges and opportunities under the environment of fierce competition in the global pharmaceutical market.At the same time, compared with the developed countries and regions, the scale effect of the pharmaceutical manufacturing industry in Beijing is relatively weak, the development starts relatively late, there are still many regional differences and constraints, resulting in the overall market competitiveness is weak.Individual development is not balanced and so on.Beijing, as the capital of our country, is an important region of China's economic development. This paper mainly takes the medicine market in Beijing as the research object, starting from the current situation of the medicine market in Beijing and even in the whole country, through the comparison and verification of various examples.This paper analyzes the development of the pharmaceutical manufacturing industry in Beijing from different angles, and explains the opportunities and challenges faced by the pharmaceutical manufacturing industry in Beijing by SWOT method.The future development trend and direction of pharmaceutical manufacturing industry are analyzed and discussed from the aspects of the internal and external environment and the changes that pharmaceutical enterprises are facing.
【學(xué)位授予單位】:首都經(jīng)濟(jì)貿(mào)易大學(xué)
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2015
【分類號(hào)】:F426.72
【參考文獻(xiàn)】
相關(guān)期刊論文 前2條
1 張金昌;波特的國(guó)家競(jìng)爭(zhēng)優(yōu)勢(shì)理論剖析[J];中國(guó)工業(yè)經(jīng)濟(jì);2001年09期
2 肖俊輝;;論我國(guó)醫(yī)藥制造業(yè)的現(xiàn)狀與發(fā)展對(duì)策[J];中國(guó)社會(huì)醫(yī)學(xué)雜志;2007年04期
相關(guān)博士學(xué)位論文 前1條
1 曹巍;重磅藥品評(píng)估及北京重磅藥品發(fā)展策略研究[D];中國(guó)人民解放軍軍事醫(yī)學(xué)科學(xué)院;2006年
,本文編號(hào):1747221
本文鏈接:http://sikaile.net/jingjilunwen/chanyejingjilunwen/1747221.html
最近更新
教材專著